Cargando…

Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis

Pulmonary fibrosis results from a plethora of abnormal pathogenetic events. In idiopathic pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in genetically and epigenetically predisposed individuals trigger recurrent cycles of alveolar epithelial cell injury, activation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrot, Carole Y., Karampitsakos, Theodoros, Herazo-Maya, Jose D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Physiological Society 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635664/ https://www.ncbi.nlm.nih.gov/pubmed/37694283 http://dx.doi.org/10.1152/ajpcell.00302.2023

Ejemplares similares

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
por: Ntatsoulis, Konstantinos, et al.
Publicado: (2021)

Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Ferroptosis in pulmonary fibrosis: an emerging therapeutic target
por: Wang, Chunyan, et al.
Publicado: (2023)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke
por: Kanazawa, Masato, et al.
Publicado: (2017)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
por: Fendl, B., et al.
Publicado: (2023)

Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis
por: Choi, Sun Mi, et al.
Publicado: (2023)

Increased lipocalin-2 expression in pulmonary inflammation and fibrosis
por: Galaris, Apostolos, et al.
Publicado: (2023)

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2021)

Nanoparticles targeting monocytes and macrophages as diagnostic and therapeutic tools for autoimmune diseases
por: Álvarez, Karen, et al.
Publicado: (2023)

Novel therapeutic approaches for pulmonary fibrosis
por: Datta, Arnab, et al.
Publicado: (2011)

Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
por: Chang, Xin, et al.
Publicado: (2020)

Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis
por: Chauvin, Pierre, et al.
Publicado: (2022)

Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis
por: Öz, Hasan H., et al.
Publicado: (2022)

Innate Immune Cells: Monocytes, Monocyte-Derived Macrophages and Microglia as Therapeutic Targets for Alzheimer’s Disease and Multiple Sclerosis
por: Fani Maleki, Adham, et al.
Publicado: (2019)

Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies
por: Caverzán, Matías Daniel, et al.
Publicado: (2023)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases
por: Cadamuro, Massimiliano, et al.
Publicado: (2020)

Multivalent nanosystems: targeting monocytes/macrophages
por: Poupot, Rémy, et al.
Publicado: (2018)

Monocytes and Macrophages as Viral Targets and Reservoirs
por: Nikitina, Ekaterina, et al.
Publicado: (2018)

Novel strategy of combined interstitial macrophage depletion with intravenous targeted therapy to ameliorate pulmonary fibrosis
por: Li, Zhongxian, et al.
Publicado: (2023)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?
por: Gillette, Devyn D., et al.
Publicado: (2014)

Monocytes, Macrophages, and Their Potential Niches in Synovial Joints – Therapeutic Targets in Post-Traumatic Osteoarthritis?
por: Haubruck, Patrick, et al.
Publicado: (2021)

A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
por: Chioccioli, Maurizio, et al.
Publicado: (2022)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
por: Ma, Hongbo, et al.
Publicado: (2022)

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
por: Bisserier, Malik, et al.
Publicado: (2019)

Human pluripotent stem cell-derived macrophages and macrophage-derived exosomes: therapeutic potential in pulmonary fibrosis
por: Rasaei, Roya, et al.
Publicado: (2022)

Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
por: Smith, Julianne N. P., et al.
Publicado: (2020)

HSP47: A Therapeutic Target in Pulmonary Fibrosis
por: Sakamoto, Noriho, et al.
Publicado: (2023)

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis
por: Lee, Chang-Min, et al.
Publicado: (2014)

Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis
por: Zhou, Dexi, et al.
Publicado: (2020)

Targeted Liposomal Drug Delivery to Monocytes and Macrophages
por: Kelly, Ciara, et al.
Publicado: (2011)

Antler stem cell exosomes alleviate pulmonary fibrosis via inhibiting recruitment of monocyte macrophage, rather than polarization of M2 macrophages in mice
por: Zhang, Guokun, et al.
Publicado: (2023)

Monocyte as a prognostic marker in patients with idiopathic pulmonary fibrosis
por: Zhu, Shiping
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nprcd4mc0mvmmn307r50irv4fe